SAN || Medical Dermatology

What’s old is new again for actinic keratoses treatment

Posted on: 31/03/2014 - 23:00

DENVER – Changes in health insurance coverage are prompting a resurgence in the use of 5-fluorouracil to treat actinic keratoses, according to Dr. Linda Susan Marcus. Not only is 5-fluorouracil...

Field of Interest: Dermatology

Type: News Item

Ustekinumab again linked to cardiovascular events

Posted on: 28/03/2014 - 17:05

WAIKOLOA, HAWAII – The anti-interleukin-12/23 biologic agents ustekinumab and briakinumab were associated with a statistically significant 4.23-fold increased risk of major adverse cardiac events in...

Field of Interest: Dermatology

Type: News Item

Psoriatic pruritus improves with TrkA-blocking drug

Posted on: 25/03/2014 - 20:05

An investigational topical drug that targets a nerve sensitization pathway showed good efficacy against chronic itch in patients with pruritic psoriasis. CT327 works by inhibiting the kinase pathway...

Field of Interest: Dermatology

Type: News Item

Tofacitinib found noninferior to etanercept for treating psoriasis

Posted on: 25/03/2014 - 17:10

DENVER – Key results from a phase III trial found that an investigational Janus kinase inhibitor was noninferior to a biologic agent for treating psoriasis. During a late-breaking session at the...

Field of Interest: Dermatology

Type: News Item

Novel agent for papulopustular rosacea found safe, effective in phase III trials

Posted on: 23/03/2014 - 19:50

DENVER – Ivermectin 1% cream applied once daily was effective and safe in treating patients with moderate to severe papulopustular rosacea, based on data from a pair of phase III studies. Ivermectin...

Field of Interest: Dermatology

Type: News Item

VIDEO: Ivermectin shows promise for treating papulopustular rosacea

Posted on: 23/03/2014 - 18:40

DENVER – A limited number of safe and effective topical medications are currently available to treat chronic papulopustular (inflammatory) rosacea. In a <link...

Field of Interest: Dermatology

Type: News Item

FDA approves PDE-4 inhibitor for treating psoriatic arthritis

Posted on: 21/03/2014 - 21:50

Apremilast, an oral phosphodiesterase-4 inhibitor, has been approved for treating adults with active psoriatic arthritis, based on the results of three studies of 1,493 patients, the Food and Drug...

Field of Interest: Dermatology

Type: News Item

FDA approves PDE-4 inhibitor for treating psoriatic arthritis

Posted on: 21/03/2014 - 21:50

Apremilast, an oral phosphodiesterase-4 inhibitor, has been approved for treating adults with active psoriatic arthritis, based on the results of three studies of 1,493 patients, the Food and Drug...

Field of Interest: Rheumatology

Type: News Item

FDA approves omalizumab for chronic idiopathic urticaria

Posted on: 21/03/2014 - 21:30

The Food and Drug Administration has approved omalizumab (Xolair) for chronic idiopathic urticaria in people 12 years of age and older who remain symptomatic despite treatment with...

Field of Interest: Dermatology

Type: News Item

VIDEO: Photodynamic therapy pearls can improve results

Posted on: 14/03/2014 - 15:40

CHAMPIONSGATE, FLA. – Do you use photodynamic therapy to treat actinic keratoses? Dr. Joel Cohen has some tips for you. At the Orlando Dermatology Aesthetic and Clinical Conference, <link...

Field of Interest: Dermatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters